ŠULCOVÁ, Alexandra and Leoš LANDA. Interaction of cannabinoid methanandamide with processes of sensitization to both behavioral and immunological methamphetamine effects in mice. In MECHOULAM, Raphael. Abstracts - NIDA International Forum 2004, San Juan, Puerto Rico. USA: US National Institute on Drug Abuse, 2004, p. 90.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Interaction of cannabinoid methanandamide with processes of sensitization to both behavioral and immunological methamphetamine effects in mice.
Name in Czech Interakce kanabinoidu metanandamidu s procesy sensitizace k behaviorálním a imunologickým účinklům metamfetaminu u myší
Authors ŠULCOVÁ, Alexandra (203 Czech Republic, guarantor) and Leoš LANDA (203 Czech Republic).
Edition USA, Abstracts - NIDA International Forum 2004, San Juan, Puerto Rico, p. 90-90, 2004.
Publisher US National Institute on Drug Abuse
Other information
Original language English
Type of outcome Proceedings paper
Field of Study 30104 Pharmacology and pharmacy
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/04:00010248
Organization unit Faculty of Medicine
Keywords in English methanandamide; methamphetamine; sensitization; mice
Tags methamphetamine, methanandamide, mice, sensitization
Changed by Changed by: prof. MUDr. Alexandra Šulcová, CSc., učo 1937. Changed: 2/9/2004 14:20.
Abstract
The phenomenon of sensitization enhancing usually stimulant behavioral response to repeatedly administered drugs of abuse has been described both in laboratory animals and human beings. There is also data available confirming a cross-sensitization between different types of drugs of abuse supporting further the hypothesis that repeated use of one drug of abuse may facilitate the consumption of other drugs. Previously we confirmed the sensitization to methamphetamine (MET) stimulatory effect on locomotor/exploratory behavior, and also to its inhibitory influence on aggression in mice. Furthermore, such sensitization was present in mice cross-sensitized with cannabinoid methanandamide (CAN). Our experiences with behavioral as well as immunological profiles of different cannabinoids received in our collaborative studies with Israel colleagues (Mechoulam R., Fride E.) gave rise to the present study comparing cross-sensitization with CAN to behavioral MET effects with their influences on immune function of leukocytes - phagocytic activity. Not only the behavioral sensitization to MET antiaggressive effects in aggressive singly-housed male mice on paired interactions with non-aggressive group-housed partners but also to inhibitory influence on leukocyte phagocytosis were registered in the present study when challenge doses were given several days apart from the pre-treatment with 5 daily doses of MET. In the same experimental design a cross-sensitization to the antiaggressive efficacy of methamphetamine was found after 5 daily doses of CAN. The 5 day treatment with CAN significantly increased phagocytosis of zymosan by leukocytes in vitro, and did not cross-sensitized to MET 5 challenge doses given 9 days later when the chemiluminometric curve signaling phagocytosis did not vary from the control one. These results confirm an interaction between the endocannabinoid system and MET brain mechanisms, and support further the hypothesis that repeated use of cannabis may smooth the progress of intake of psychostimulant drugs at least. Despite CA is reported as agonist with high affinity at CB1 cannabinoid receptor localized mainly in the CNS it stimulated after repeated doses leukocyte phagocytosis, but did not cross-sensitized to MET suppressive effect on this function.
Abstract (in Czech)
Byly potvrzeny funkční interakce mezi endokanabinboidním systémem a farmakologickými mechanismy metamfetaminu v obou studovaných parametrech.
PrintDisplayed: 4/8/2024 18:28